期刊文献+

重症肌无力相关抗体研究进展 被引量:3

下载PDF
导出
摘要 重症肌无力 (myasthenia gravis,MG)是一种由多种基因调控,多种抗体、免疫细胞、细胞因子、补体参与的自身免疫疾病,主要影响神经-肌头接头处(neuromuscular junction,NMJ)突触后膜上信号传导,多数是由乙酰胆碱受体抗体(acety-lcholine receptor antibody,AchR-Ab)介导,其确切发病机制仍然未明确[1].MG最先在1672年,由英国Thomas Willis报道;Simpson 于1960年报道该病与自身免疫功能障碍相关.与其他自身免疫疾病一样,MG易复发.对MG发病机制深入研究、提高诊断和治疗水平对于提高患者生活质量有重大意义.
出处 《脑与神经疾病杂志》 2014年第1期75-78,共4页 Journal of Brain and Nervous Diseases
基金 河北省科技厅科技支撑计划指令项目(08276101D-71)
  • 相关文献

参考文献18

  • 1Gilhus NE . Autoimmune myasthenia gravis. Expert Rev Neurother, 2009,9 : 351-358.
  • 2Gomez AM, Van Den Broeck J, Vrolix K, et al. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction. Autoimmunity, 2010,43 : 353-370.
  • 3Nasim K, Elsayed S, Pitout JD, et al. New method for laboratory detection of AmpC beta lactamases in Escherichia coli and Klebsiella pneumoniae.J Clin Microbiol, 2004,42 : 4799-4802.
  • 4Liyanage Y, Hoch W,Beeson D, et al. The agrin/muscle-specific kinase pathway:new targets for autoimmune and genetic disorde~ at the neur- omuscularjunction.Muscle Nerve,2002,25:4-16.
  • 5Buonanno A, Fischbach GD. Neuregulin and ErbB receptor signalingpathways in the nervous system. Curt Opin Neurobiol, 2001, 11:287-296.
  • 6Tanabe T,NodaM, FurutaniY, et al. Primary structre of betasubunit precursor of calf-muscle acetylcholine receptor deduced form cDNA sequence. Eur J Biochem, 1984, 114 : 11- !7.
  • 7Levinson AI, Zheng Y, Gaulton G, et al. Intrathymic expression of neuromuscular acetylcholine receptors and the immunpathogenesis of myasthenia gravis, lmmunol Res,2003,27 : 399-408.
  • 8Hoch W, MC conville J, Helme S, et al.Auto-antibodies to the tyrosine kinase musk in patients with myasthenia gravis without acetylcholine receptor antibodies.Natl Med , 2001,7 : 365-368.
  • 9王中魁,魏东宁.肌肉特异性酪氨酸激酶抗体与重症肌无力[J].中国神经免疫学和神经病学杂志,2009,16(6):442-444. 被引量:4
  • 10Shigemoto K , KuboS, Maruyama N, et al.Induetion of myasthenia by immunization against muscle specifickinase. J C linln vest , 2006, 116 : 1016-1024.

二级参考文献18

  • 1Burden SJ. Building the vertebrate neuromuscular synapse[J]. J Neurobiol, 2002, 53:501-511.
  • 2Misgeld T, Kummer TT, Lichtman JW, etal. Agrin promotes synaptic differentiation by counteracting an inhibitory effect of neurotransmitter[J]. Proe Natl Acad Sci USA, 2005,102 : 11088-11093.
  • 3Ngo ST, Noakes PG, Phillips WD. Neural agrin: a synaptic stabiliser[J]. Int J Biochem Cell Biol,2007, 39:863- 867.
  • 4Shigemoto K, Kubo S, Maruyama N, etal. Induction of myasthenia by immunization against muscle-specific kinase[J]. J Clin Invest, 2006,116 :1016-1024.
  • 5Cole RN, Reddel SW, Gervasio OL, et al. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction[J]. Ann Neurol, 2008,63 : 782-789.
  • 6McConville J, Farrugia ME, Beeson D, et al. Detection and characterization of MuSK antibodies in seronegative myasthenia gravis[J]. Ann Neurol, 2004,55: 580-584.
  • 7Vincent A, Bowen J, Newsom-Davis J, etal. Seronegative generalized myasthenia gravis: clinical features, antibodies, and their targets[J]. Lancet Neurol, 2003,2:99-106.
  • 8Yeh JH, Chen WH, Chiu HC, et al. Low frequeney of MuSK antibody in generalized seronegative myasthenia gravis among Chinese [J]. Neurology, 2004, 52:1920-1921.
  • 9Ohta K, Shigemoto K, Fujinami A. Clinical and experimental features of MuSK antibody positive MG in Japan[J]. Eur J Neurol, 2007,14 : 1029-1034.
  • 10Kostera-Pruszczyk A, Kaminska A, Dutkiewicz M, et al. MuSK-positive myasthenia gravis is rare in the Polish population[J].Eur J Neurol, 2008, 15:720- 724.

共引文献7

同被引文献65

引证文献3

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部